Skip to content
OpenCapital
Get started

Kura Oncology KURA Market capitalization

Market capitalization at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Exelixis logo
ExelixisEXEL
$11.29B+10.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06B+95.0%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$1.23B+467%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M—
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Enterprise value$927.97M+95.5%
P/S13.2×+3.9×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Computed from the period-end share price: $718.12M.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's market capitalization?
Kura Oncology (KURA) reported market capitalization of $718.12M in Q1 2026.
How has Kura Oncology's market capitalization changed year-over-year?
Kura Oncology's market capitalization increased by 34.7% year-over-year, from $532.98M to $718.12M.
What is the long-term trend for Kura Oncology's market capitalization?
Over 5 years (2020 to 2025), Kura Oncology's market capitalization has grown at a -16.0% compound annual growth rate (CAGR), from $2.16B to $904.11M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.